These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 17316536)

  • 1. A comprehensive urinary metabolomic approach for identifying kidney cancerr.
    Kind T; Tolstikov V; Fiehn O; Weiss RH
    Anal Biochem; 2007 Apr; 363(2):185-95. PubMed ID: 17316536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of volatile human urinary metabolome by solid-phase microextraction in combination with gas chromatography-mass spectrometry for biomarker discovery: application in a pilot study to discriminate patients with renal cell carcinoma.
    Monteiro M; Carvalho M; Henrique R; Jerónimo C; Moreira N; de Lourdes Bastos M; de Pinho PG
    Eur J Cancer; 2014 Jul; 50(11):1993-2002. PubMed ID: 24820933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing genetic algorithms for feature selection in comprehensive metabolic profiling approach.
    Zou W; Tolstikov VV
    Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1312-24. PubMed ID: 18383216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
    Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
    Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrophilic interaction and reversed-phase ultra-performance liquid chromatography TOF-MS for metabonomic analysis of Zucker rat urine.
    Gika HG; Theodoridis GA; Wilson ID
    J Sep Sci; 2008 May; 31(9):1598-608. PubMed ID: 18461568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery.
    Lin L; Huang Z; Gao Y; Yan X; Xing J; Hang W
    J Proteome Res; 2011 Mar; 10(3):1396-405. PubMed ID: 21186845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes.
    Del Boccio P; Raimondo F; Pieragostino D; Morosi L; Cozzi G; Sacchetta P; Magni F; Pitto M; Urbani A
    Electrophoresis; 2012 Feb; 33(4):689-96. PubMed ID: 22451062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
    Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fingerprinting of rat urine by LC/MS Part 2. Data pretreatment methods for handling of complex data.
    Idborg H; Zamani L; Edlund PO; Schuppe-Koistinen I; Jacobsson SP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 828(1-2):14-20. PubMed ID: 16198158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic profiling of rat serum associated with isoproterenol-induced myocardial infarction using ultra-performance liquid chromatography/time-of-flight mass spectrometry and multivariate analysis.
    Zhang HY; Chen X; Hu P; Liang QL; Liang XP; Wang YM; Luo GA
    Talanta; 2009 Jul; 79(2):254-9. PubMed ID: 19559874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human cerebrospinal fluid metabolome.
    Wishart DS; Lewis MJ; Morrissey JA; Flegel MD; Jeroncic K; Xiong Y; Cheng D; Eisner R; Gautam B; Tzur D; Sawhney S; Bamforth F; Greiner R; Li L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(2):164-73. PubMed ID: 18502700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative urine analysis by liquid chromatography-mass spectrometry and multivariate statistics: method development, evaluation, and application to proteinuria.
    Kemperman RF; Horvatovich PL; Hoekman B; Reijmers TH; Muskiet FA; Bischoff R
    J Proteome Res; 2007 Jan; 6(1):194-206. PubMed ID: 17203964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophilic interaction chromatography coupled to MS for metabonomic/metabolomic studies.
    Spagou K; Tsoukali H; Raikos N; Gika H; Wilson ID; Theodoridis G
    J Sep Sci; 2010 Mar; 33(6-7):716-27. PubMed ID: 20187037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
    Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
    J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gas chromatography/flame ionisation detection mass spectrometry for the detection of endogenous urine metabolites for metabonomic studies and its use as a complementary tool to nuclear magnetic resonance spectroscopy.
    Fancy SA; Beckonert O; Darbon G; Yabsley W; Walley R; Baker D; Perkins GL; Pullen FS; Rumpel K
    Rapid Commun Mass Spectrom; 2006; 20(15):2271-80. PubMed ID: 16810707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
    Chen J; Wang W; Lv S; Yin P; Zhao X; Lu X; Zhang F; Xu G
    Anal Chim Acta; 2009 Sep; 650(1):3-9. PubMed ID: 19720165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophilic interaction chromatography for mass spectrometric metabonomic studies of urine.
    Cubbon S; Bradbury T; Wilson J; Thomas-Oates J
    Anal Chem; 2007 Dec; 79(23):8911-8. PubMed ID: 17973349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.
    Wu H; Xue R; Dong L; Liu T; Deng C; Zeng H; Shen X
    Anal Chim Acta; 2009 Aug; 648(1):98-104. PubMed ID: 19616694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An approach to enhancing coverage of the urinary metabonome using liquid chromatography-ion mobility-mass spectrometry.
    Harry EL; Weston DJ; Bristow AW; Wilson ID; Creaser CS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(2):357-61. PubMed ID: 18502703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry.
    Issaq HJ; Nativ O; Waybright T; Luke B; Veenstra TD; Issaq EJ; Kravstov A; Mullerad M
    J Urol; 2008 Jun; 179(6):2422-6. PubMed ID: 18433783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.